Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/4/2024 | 4:30 PM – 6:00 PM | Room W175
Block Symposium—Enhancing and Shaping Vaccine Responses
Moderators
Michael Schotsaert, Icahn Sch. of Med., Mount Sinai, USA
Stephen Yeung, Weill Cornell Med.
Nanoparticle immunoadjuvant complexes augment antigen-specific germinal center responses to enhance humoral immunity
Presentation Time: 04:30 PM–04:45 PM
Abstract ID: 5557 - B
Presenting Author:
Nicholas J Tursi, Wistar Inst., University of Pennsylvania Perelman School of Medicine
Co-Authors:
Toshitha Kannan, Wistar Inst.; Jennifer Londregan, Univ. of Pennsylvania Perelman Sch. of Med.; Katlyn Lederer, Univ. of Pennsylvania Perelman Sch. of Med.; Michaela Helble, Wistar Inst.; Ebony N Gary, Wistar Inst.; Nicole Bedanova, Wistar Inst.; Ivan Maillard, Univ. of Pennsylvania Perelman Sch. of Med.; David Allman, Univ. of Pennsylvania Perelman Sch. of Med.; Amelia Escolano, Wistar Inst.; Andrew Kossenkov, Wistar Inst.; Daniel W Kulp, Wistar Inst.; David B Weiner, Wistar Inst.;
View Abstract Details
Lipid nanoparticle encapsulation enhances the immunogenicty of a SARS-CoV-2 Delta variant-based DNA vaccine and enables protection against heterologous omicron subvariants
Presentation Time: 04:45 PM–05:00 PM
Abstract ID: 5136 - B
Presenting Author:
Levi Tamming, Univ. Ottawa
Co-Authors:
Diana Duque, Human Hlth. Therapeut. Res. Ctr., Natl. Res. Cou. Canada; Casey Lansdell; Sathya Raman; Lisheng Wang, Univ. Ottawa; Anh Tran, Human Hlth. Therapeut. Res. Ctr., Natl. Res. Cou. Canada; Michael J.W Johnston; Xuguang Li;
View Abstract Details
Plasmid-encoded CCL27 co-delivery enhances heterologous protection from respiratory virus challenge
Presentation Time: 05:00 PM–05:15 PM
Abstract ID: 6029 - B
Presenting Author:
Ebony N Gary, Wistar Inst.
Co-Authors:
Nicholas J Tursi, Wistar Inst.; Bryce Warner, Pub. Hlth. Agcy. of Canada; Abigail Trachtman, Wistar Inst.; Ami Patel, Wistar Inst.; Darwyn Kobasa, Pub. Hlth. Agcy. of Canada; David B Weiner, Wistar Inst.;
View Abstract Details
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities
Presentation Time: 05:15 PM–05:30 PM
Abstract ID: 4465 - B
Presenting Author:
Catarina E Hioe, Icahn Sch. of Med., Mount Sinai, James J. Peters VA Med. Ctr.
Co-Authors:
Jéromine Klingler Klingler, Icahn Sch. of Med., Mount Sinai; Shreyas Kowdle, Icahn Sch. of Med., Mount Sinai; Juan C Bandres, James J. Peters VA Med. Ctr.; Rozita Emami-Gorizi, James J. Peters VA Med. Ctr.; Raymond A Alvarez, Icahn Sch. of Med., Mount Sinai; Fatima Amanat, Icahn Sch. of Med., Mount Sinai; Charles Gleason, Icahn Sch. of Med., Mount Sinai; Komal Srivastava, Icahn Sch. of Med., Mount Sinai; Viviana Simon, Icahn Sch. of Med., Mount Sinai; Claudia Perandones, ANLIS Malbrán; Benhur Lee, Icahn Sch. of Med., Mount Sinai;
View Abstract Details
Trained immunity generated by the recombinant zoster vaccine (RZV)
Presentation Time: 05:30 PM–05:45 PM
Abstract ID: 5167 - B
Presenting Author:
Michael J Johnson, Univ. of Colorado Anschutz Med. Campus
Co-Authors:
Megan Crotteau, Univ. of Colorado Anschutz Med. Campus; Debashis Ghosh, Univ. of Colorado Anschutz Med. Campus; Myron J Levin, Univ. of Colorado Anschutz Med. Campus; Adriana Weinberg, Univ. of Colorado Anschutz Med. Campus;
View Abstract Details